[Edaily Starin Gim Ga Yeong Reporter] Actress Hyeri explained the process of taking legal action against online trolls. Hye-ri (Photo = Edaily DB)On the 13th, Hye-ri’s agency, Sublime, stated, “We would like to provide an update on the progress of our legal action regarding malicious posts about Hye-ri,” adding, “Based on data collected through our own monitoring and reports submitted by fans, we have been taking continuous legal action since October 2024.” They continued, “As a result, numerous criminal charges—including violations of the Act on Promotion of Information and Communications Network Utilization and Information Protection (defamation) and insults—have been substantiated, and depending on the severity of each case, fines or indictments are being imposed,” and "We would like to inform you that we are currently conducting constant monitoring of all malicious acts targeting our artists, including defamation, insults, sexual harassment, and the dissemination of false information, and that legal action is being taken continuously, even if we do not announce the status of complaints or investigations in real time," the agency stated. The agency added, “We plan to continue taking strong legal measures without any leniency or settlement to protect the rights and interests of our artists.” Actress Hye-ri, formerly of the girl group Girls’ Day, is currently appearing in the ENA drama *A Dream for You*. *A Dream for You* recorded a viewership rating of 2.5% on the 11th.
Six Samsung affiliates, including SamsungElectronics, SAMSUNG C&T CORPORATION, and Samsung SDS, are investing $1 billion (approximately 1.4 trillion won) in the artificial intelligence (AI) infrastruc…
#Cellbion Co., Ltd, a company specializing in radiopharmaceuticals (RPT), has cleared the final clinical hurdle for its next-generation prostate cancer drug, setting the stage for a quantum leap in it…
Hwang Seon-jin, Vice President of AprilBio Co.,Ltd. (Photo: AprilBio Co.,Ltd.)
AprilBio Co.,Ltd.(397030)has recruited Vice President Hwang Seon-jin, who has accumulated clinical development experi…